Panobinostat three days in a row? Have your eyes glazed over yet? I understand some of you aren't interested in drug development details. But mixed reviews or not, FDA approval of panobinostat is a big deal. After Velcade, Revlimid and Doxil were approved as multiple myeloma therapies nine or ten years ago, there wasn't a
This weekend I shared how I was becoming anxious and frazzled with the added responsibility and concern for my dying father. The mental and emotional health of myeloma patients and caregivers is an under-served and rarely addressed part of our lives. You know me; I'm not going to let this go. I will get back
There is a lot going on in the world of myeloma research. Fortunately for us, it seems like these hard working scientists never sleep! And things certainly don't stop because I'm in the hospital having a hip replaced! To start, here's a link to an interesting research paper that was published in the latest edition
Yesterday I promised more information about vorinostat. Here is what ChemoCare.Com has to say about the drug:How Vorinostat Works: Cancerous tumors are characterized by cell division, which is no longer controlled as it is in normal tissue. "Normal" cells stop dividing when they come into contact with like cells, a mechanism known as contact inhibition.